SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-17-136738
Filing Date
2017-04-25
Accepted
2017-04-25 16:10:55
Documents
3
Period of Report
2017-04-25

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d384067d6k.htm 6-K 10938
2 EX-99.1 d384067dex991.htm EX-99.1 7224
3 GRAPHIC g384067ex991pg01.jpg GRAPHIC 27775
  Complete submission text file 0001193125-17-136738.txt   57352
Mailing Address 85B PARK DRIVE MILTON PARK ABINGDON X0 OX14 4RY
Business Address 85B PARK DRIVE MILTON PARK ABINGDON X0 OX14 4RY 44-123-544-3939
Summit Therapeutics plc (Filer) CIK: 0001599298 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 0114
Type: 6-K | Act: 34 | File No.: 001-36866 | Film No.: 17781206
SIC: 2834 Pharmaceutical Preparations